Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sanofi S.A. | 4 | 0 | 0 | 0 | €100.90 | €109.00 | 8.028% |
| Pfizer Inc. | 29 | 4 | 5 | 0 | €26.04 | €40.64 | 56.078% |
| Gilead Sciences Inc | 11 | 0 | 1 | 0 | €77.06 | €85.74 | 11.260% |
| Geron Corp. | 15 | 0 | 1 | 0 | €3.96 | €5.55 | 40.182% |
| Xencor Inc. | 17 | 0 | 1 | 0 | €17.40 | €31.37 | 80.259% |
| arGEN X BV | 1 | 0 | 0 | 0 | €484.20 | €470.00 | -2.933% |
| Exelixis Inc. | 22 | 0 | 4 | 0 | €23.95 | €26.01 | 8.586% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €22.60 | €28.29 | 25.180% |
| Corcept Therapeutics Inc. | 19 | 0 | 2 | 0 | €40.81 | €41.65 | 2.052% |
| AnaptysBio Inc | 13 | 0 | 1 | 0 | €31.60 | €46.24 | 46.329% |
| Sangamo Therapeutics Inc. | 11 | 15 | 0 | 0 | €0.72 | €3.64 | 408.902% |
| Viking Therapeutics Inc | 6 | 0 | 2 | 0 | €59.18 | €110.00 | 85.874% |
| Lexicon Pharmaceuticals Inc. | 12 | 0 | 3 | 0 | €1.54 | €9.07 | 490.717% |
| Enanta Pharmaceuticals Inc. | 6 | 2 | 1 | 0 | €9.85 | €24.75 | 151.251% |
| Immunogen Inc. | 1 | 0 | 0 | 0 | €28.97 | - | - |
| Insmed Inc. | 46 | 0 | 2 | 0 | €64.50 | €76.89 | 19.202% |
| Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | €0.74 | €13.88 | 1776.122% |
| Amneal Pharmaceuticals Inc | 1 | 0 | 0 | 0 | €7.90 | €10.00 | 26.582% |
| SELLAS Life Sciences Group Inc | 1 | 0 | 1 | 0 | €1.13 | €1.50 | 32.743% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €55.19 | €55.00 | -0.344% |
| Hutchison China MediTech Ltd ADR | 3 | 0 | 0 | 0 | €18.00 | €20.23 | 12.391% |
| AbbVie Inc. | 33 | 0 | 0 | 0 | €176.98 | €181.45 | 2.524% |
| Merck KGaA | 8 | 1 | 4 | 0 | €155.30 | €172.00 | 10.753% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Novartis AG ADR | 4 | 0 | 1 | 0 | €104.00 | €112.40 | 8.074% |